by Stacey Johnson | Mar 31, 2015
. In May 2012, the Stem Cell Network (SCN) and the Centre for Commercialization of Regenerative Medicine (CCRM) launched Signals Blog, an evolution of SCN’s popular Stem Cell Network Blog and the brainchild of Lisa Willemse, Director of Communications at SCN. Beyond...
by Stem Cell Network | May 16, 2012
Welcome to Signals Blog, the new home and new name for the Stem Cell Network Blog. Why the change? After nearly four years, 207 blog posts and several “best of” awards, the SCN Blog finally outgrew its dish, so to speak. Late last year, we began planning...
by Paul Krzyzanowski | May 16, 2012
Commercialization plenary summary: part 4 of 4 The last speaker of the commercialization plenary at the Till and McCulloch Meetings earlier this month was Dr. Stephen Minger from GE Healthcare, who shared GE’s perspective regarding the therapeutic and research...
by David Kent | May 2, 2012
Anticipatory ethics and the problem of expectations One of my favorite things about Canadian Stem Cell Network meetings (now renamed the Till and McCulloch Meetings) is the integration into the main programming of Ethical, Legal, and Social Issues (ELSI). It...
by Lisa Willemse | Feb 1, 2012
Some updates and news items of note: Call for boycott of subscriber-based journals gains momentum The ongoing friction between proponents of open access and the academic publishers has jumped into the spotlight once again with calls from a number of academics, most...
Comments